Author

A. B. Montgomery

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Approach:statistical model· 2 Assay:ATAC-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1 Organism:Drosophila· 1

Frequent Co-Authors

A. Bharat· 1 shared A. Hayat· 1 shared A. Misharin· 1 shared A. R. Rodan· 1 shared A. Rothenfluh· 1 shared B. Bardestein-Wald· 1 shared C. B. Merrill· 1 shared C. M. Cuda· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Bharat

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Harnessing changes in open chromatin determined by ATAC-seq to generate insulin-responsive reporter constructs.

C. B. Merrill, A. B. Montgomery, M. A. Pabon, A. R. Rodan, A. Rothenfluh

The paper uses ATAC-seq and RNA-seq to identify insulin-responsive enhancer regions in Drosophila cells and validates their inducibility with luciferase reporters.

bioRxiv · May 6, 2021Cell Biology

Tissue-resident, extravascular CD64-Ly6C- population forms a critical barrier for inflammation in the synovium

A. B. Montgomery, S.-Y. Chen, G. Gadhvi, M. G. Mayr, C. M. Cuda, S. Dominguez, H. M. Makinde, A. Misharin, M. G. Gurra, M. AKBARPOUR, A. Bharat, G. R. S. Bundinger, D. R. Winter, H. Perlman

The paper identifies and characterizes two distinct synovial monocyte populations, showing that the extravascular population is critical for RA-like disease development.

bioRxiv · Feb 25, 2021 · PreprintImmunology

Inhalation: A means to explore and optimize nintedanib's pharmacokinetic/pharmacodynamic relationship

G. Epstein-Shochet, S. Pham, S. Beck, S. Naiel, O. Mekhael, S. Revill, A. Hayat, M. Vierhout, B. Bardestein-Wald, D. Shitrit, K. Ask, A. B. Montgomery, M. Kolb, M. Surber

This paper investigates the pharmacokinetic/pharmacodynamic relationship of inhaled nintedanib for IPF treatment, showing that short-duration inhaled doses can achieve equivalent or superior efficacy compared to long-duration oral doses.

bioRxiv · Mar 27, 2020Pharmacology & Toxicology